Type 1 Diabetes: Advances in Research and Management

Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, necessitating lifelong insulin therapy for glycemic control. Recent advances in type 1 diabetes research focus on elucidating the immunopathogenesis of the disease and developing immunomodulatory therapies aimed at halting or delaying beta cell destruction. Innovations in insulin delivery systems, such as closed-loop systems or beta cell replacement therapies, aim to improve glycemic control and enhance quality of life for individuals with type 1 diabetes. Patient-centered care models emphasize individualized management strategies tailored to lifestyle preferences and treatment goals, highlighting the importance of multidisciplinary diabetes care teams in optimizing outcomes for individuals with type 1 diabetes.

    Related Conference of Type 1 Diabetes: Advances in Research and Management

    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France

    Type 1 Diabetes: Advances in Research and Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in